0001209191-22-010403.txt : 20220216 0001209191-22-010403.hdr.sgml : 20220216 20220216201043 ACCESSION NUMBER: 0001209191-22-010403 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220209 FILED AS OF DATE: 20220216 DATE AS OF CHANGE: 20220216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Seline E. CENTRAL INDEX KEY: 0001769866 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 22645298 MAIL ADDRESS: STREET 1: C/O REZOLUTE, INC. STREET 2: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562020050 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 710 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-871-0761 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 710 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-09 0 0001124105 CATALYST BIOSCIENCES, INC. CBIO 0001769866 Miller Seline E. C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 710 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP Finance; Interim CFO & PAO Common Stock 2022-02-09 5 P 0 E 3250 0.46 A 3250 D Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2022. /s/ Seline Miller 2022-02-15